Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nesina in combination with thiazolidinediones approved in Japan for diabetes

Aug. 24, 2010

Zydus-Cadila identifies new GPR119 receptor agonists

Aug. 24, 2010

Pfizer discloses new inhibitors of DGAT-1

Aug. 23, 2010

New DGAT-1 inhibitors claimed by Banyu Pharmaceutical

Aug. 23, 2010

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Aug. 23, 2010

GCC-2680 shows promise as obesity therapeutic based on preclinical data

Aug. 23, 2010

Kalypsys claims new GPR119 receptor agonists

Aug. 23, 2010

Repros seeks meeting with FDA to discuss phase III Androxal protocol

Aug. 19, 2010

Depomed to begin phase III trial of Serada for menopausal hot flashes

Aug. 18, 2010

BioMarin to evaluate neuropsychiatric effects of Kuvan in phase IIIb trial in PKU

Aug. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...